MB
MPM BIOIMPACT LLC
BOSTON MA · SEC CIK 0001687078
$1.64B2026Q2 reported value
37Positions
55.3%Top 10 weight · largest 10.8%
7 / 11New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
RARE New+$47.35M
BIOA New+$40.87M
CGEM Added+$37.93M
TSHA New+$30.64M
ABVX Added+$30.53M
2026Q2 top sells estimated at quarter-end value
AGIO Sold out-$44.19M
XENE Sold out-$34.23M
EVMN Sold out-$33.47M
CYTK Sold out-$32.95M
DBVT Reduced-$25.37M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | $177.21M | 10.81% | 9,731,341 | 2,083,073 | 27.2% | $37.93M | Added |
| AKTS | Aktis Oncology, Inc. | $155.86M | 9.50% | 4,835,872 | 0 | 0.0% | — | Unchanged |
| LQDA | Liquidia Corporation | $110.52M | 6.74% | 1,386,174 | -18,984 | -1.4% | -$1.51M | Reduced |
| RVMD | Revolution Medicines, Inc. | $92.23M | 5.62% | 492,483 | -14,293 | -2.8% | -$2.68M | Reduced |
| CORT | Corcept Therapeutics, Inc. | $67.04M | 4.09% | 771,028 | -214,672 | -21.8% | -$18.67M | Reduced |
| EWTX | Edgewise Therapeutics Inc | $65.85M | 4.02% | 1,620,780 | -39,916 | -2.4% | -$1.62M | Reduced |
| TVTX | Travere Therapeutics Inc | $63.78M | 3.89% | 1,122,731 | -10,634 | -0.9% | -$604,118 | Reduced |
| DBVT | DBV Technologies S A | $60.13M | 3.67% | 3,666,284 | -1,547,077 | -29.7% | -$25.37M | Reduced |
| TRVI | Trevi Therapeutics Inc | $57.32M | 3.50% | 3,073,577 | -224,853 | -6.8% | -$4.19M | Reduced |
| ALMS | Alumis Inc | $56.82M | 3.46% | 2,019,020 | -367,509 | -15.4% | -$10.34M | Reduced |
| QURE | Uniqure NV | $56.46M | 3.44% | 1,225,855 | -143,376 | -10.5% | -$6.60M | Reduced |
| RARE | Ultragenyx Pharmaceuticals, Inc. | $47.35M | 2.89% | 1,418,215 | 1,418,215 | — | $47.35M | New |
| RLAY | Relay Therapeutics Inc. | $45.20M | 2.76% | 2,415,672 | 56,086 | 2.4% | $1.05M | Added |
| ABVX | Abivax SA | $44.82M | 2.73% | 336,347 | 229,079 | 213.6% | $30.53M | Added |
| DYN | Dyne Therapeutics, Inc. | $42.69M | 2.60% | 1,922,093 | 513,941 | 36.5% | $11.41M | Added |
| DNTH | Dianthus Therapeutics Inc | $40.94M | 2.50% | 420,002 | -3,980 | -0.9% | -$387,970 | Reduced |
| BIOA | BIOAGE Labs Inc | $40.87M | 2.49% | 1,667,661 | 1,667,661 | — | $40.87M | New |
| URGN | Urogen Pharma Ltd | $34.35M | 2.09% | 933,415 | -10,388 | -1.1% | -$382,278 | Reduced |
| MLTX | MoonLake Immunotherapeutics | $31.29M | 1.91% | 1,606,967 | -204,115 | -11.3% | -$3.97M | Reduced |
| PVLA | Palvella Therapeutics Inc | $31.18M | 1.90% | 204,027 | -2,377 | -1.2% | -$363,253 | Reduced |
| TSHA | Taysha Gene Therapies, Inc. | $30.64M | 1.87% | 4,500,000 | 4,500,000 | — | $30.64M | New |
| SNDX | Syndax Pharmaceuticals Inc | $29.15M | 1.78% | 1,333,523 | -7,210 | -0.5% | -$157,611 | Reduced |
| GLUE | Monte Rosa Therapeutics Inc | $28.10M | 1.71% | 1,161,081 | -15,847 | -1.3% | -$383,497 | Reduced |
| ZURA | Zura Bio Ltd. | $26.39M | 1.61% | 4,472,843 | 4,472,843 | — | $26.39M | New |
| NTRA | Natera Inc | $25.15M | 1.53% | 92,638 | -436 | -0.5% | -$118,352 | Reduced |
| STOK | Stoke Therapeutics Inc | $23.67M | 1.44% | 723,314 | -43,724 | -5.7% | -$1.43M | Reduced |
| ANL | Adlai Nortye Ltd | $22.27M | 1.36% | 1,936,291 | 1,936,291 | — | $22.27M | New |
| BLTE | Belite Bio Inc | $21.13M | 1.29% | 137,208 | 49,163 | 55.8% | $7.57M | Added |
| — | Forte Biosciences, Inc. | $20.98M | 1.28% | 987,448 | -13,234 | -1.3% | -$281,222 | Reduced |
| ORIC | Oric Pharmaceuticals Inc | $20.38M | 1.24% | 1,882,162 | 78,217 | 4.3% | $847,090 | Added |
| TARS | Tarsus Pharmaceuticals Inc | $20.27M | 1.24% | 322,007 | -7,743 | -2.3% | -$487,344 | Reduced |
| ANNX | Annexon Inc | $20.24M | 1.23% | 3,544,354 | 3,544,354 | — | $20.24M | New |
| DRUG | Bright Minds Biosciences Inc | $14.19M | 0.87% | 202,114 | -10,061 | -4.7% | -$706,282 | Reduced |
| TRDA | Entrada Therapeutics, Inc. | $9.22M | 0.56% | 1,253,053 | 1,253,053 | — | $9.22M | New |
| ACRS | Aclaris Therapeutics Inc | $5.51M | 0.34% | 1,042,467 | 650,549 | 166.0% | $3.44M | Added |
| — | Context Therapeutics Inc | $719,542 | 0.04% | 1,299,046 | -9,380,345 | -87.8% | -$5.20M | Reduced |
| — | Werewolf Therapeutics, Inc. | $28,851 | 0.00% | 80,142 | -1,128,668 | -93.4% | -$406,319 | Reduced |
| AGIO | Agios Pharmaceuticals Inc | $0 | 0.00% | 0 | -1,306,261 | -100.0% | -$44.19M | Sold out |
| XENE | Xenon Pharmaceuticals Inc | $0 | 0.00% | 0 | -588,706 | -100.0% | -$34.23M | Sold out |
| EVMN | Evommune Inc | $0 | 0.00% | 0 | -1,455,863 | -100.0% | -$33.47M | Sold out |
| CYTK | Cytokinetics Inc | $0 | 0.00% | 0 | -500,000 | -100.0% | -$32.95M | Sold out |
| CRVS | Corvus Pharmaceuticals Inc | $0 | 0.00% | 0 | -1,674,875 | -100.0% | -$24.50M | Sold out |
| CLYM | Climb Bio Inc | $0 | 0.00% | 0 | -2,593,439 | -100.0% | -$17.77M | Sold out |
| ARQT | Arcutis Biotherapeutics Inc | $0 | 0.00% | 0 | -733,966 | -100.0% | -$17.29M | Sold out |
| ZYME | Zymeworks, Inc. | $0 | 0.00% | 0 | -565,249 | -100.0% | -$14.15M | Sold out |
| VRDN | Viridian Therapeutics Inc | $0 | 0.00% | 0 | -649,873 | -100.0% | -$12.71M | Sold out |
| — | enGene Holdings, Inc. | $0 | 0.00% | 0 | -1,845,373 | -100.0% | -$12.57M | Sold out |
| ALLO | Allogene Therapeutics, Inc. | $0 | 0.00% | 0 | -2,242,933 | -100.0% | -$5.47M | Sold out |